The forecast share of corresponding/leading authors in scientific publications in biomedical engineering in Japan shows stability from 2024 to 2028, with a slight decline noted in 2027 and 2028 at 96.02%. This metric remained consistent at 96.03% from 2024 to 2026, indicating a negligible change from 2023, where it also stood near 96.02%. No significant year-on-year variations were observed, signifying a stable output. The compound annual growth rate (CAGR) remains effectively neutral over the five-year forecast period.
Trends to watch for include any shifts in global research collaboration strategies and funding policies, which could influence authorship dynamics and shift current equilibrium in the Japanese biomedical engineering publications sector.
